Literature DB >> 34025823

Using Deep Learning Model for Adapting and Managing COVID-19 Pandemic Crisis.

Mohammad Alodat1.   

Abstract

The purpose of current paper is to create a smart and effective tool for telemedicine to early detect and diagnose COVID-19 disease and therefore help to manage Pandemic Crisis (MCPC) in Sultanate of Oman, as a tool for future pandemic containment. In this paper, we used tools to create robust models in real-time to support Telemedicine, it is Machine Learning (ML), Deep Learning (DL), Convolutional Neural Networks using Tensorflow (CNN-TF), and CNN Deployment. These models will assist telemedicine, 1) developing Automated Medical Immediate Diagnosis service (AMID). 2) Analysis of Chest X-rays image (CXRs). 3) Simplifying Classification of confirmed cases according to its severity. 4) Overcoming the lack of experience, by improving the performance of medical diagnostics and providing recommendations to the medical staff. The results show that the best Regression among the five Regression models is Random Forest Regression. while the best classification among the eight classification models and Recurrent Neural Network using Tensorflow (RNNTF) is Random Forest classification, and the best Clustering model among two Clustering models is K-Means++. Furthermore, CNN-TF model was able to discriminate between those with positive cases Covid-19 and those with negative cases.
© 2021 The Author(s). Published by Elsevier B.V.

Entities:  

Keywords:  COVID-19; Convolutional Neural Networks; Deep Learning; Machine Learning; Sultanate of Oman; Tensorflow

Year:  2021        PMID: 34025823      PMCID: PMC8128670          DOI: 10.1016/j.procs.2021.03.070

Source DB:  PubMed          Journal:  Procedia Comput Sci


  1 in total

Review 1.  Telemedicine and artificial intelligence to support self-isolation of COVID-19 patients: Recent updates and challenges.

Authors:  Jessica A Huang; Intan R Hartanti; Michelle N Colin; Dian Ae Pitaloka
Journal:  Digit Health       Date:  2022-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.